Cargando…

Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study

OBJECTIVE: To identify risk factors for functional decline after hospitalization for Gram-negative bacteremia. PATIENTS AND METHODS: A prospective cohort study based on a randomized controlled trial conducted between January 1, 2013 and August 31, 2017 in Israel and Italy. Hospitalized patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Turjeman, Adi, Koppel, Fidi, Franceschini, Erica, Yahav, Dafna, Dolci, Giovanni, Babich, Tanya, Bitterman, Roni, Neuberger, Ami, Ghanem-Zoubi, Nesrin, Santoro, Antonella, Eliakim-Raz, Noa, Pertzov, Barak, Stern, Anat, Dickstein, Yaakov, Maroun, Elias, Zayyad, Hiba, Meschiari, Marianna, Bishara, Jihad, Goldberg, Elad, Venturelli, Claudia, Mussini, Cristina, Paul, Mical, Leibovici, Leonard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598031/
https://www.ncbi.nlm.nih.gov/pubmed/34788325
http://dx.doi.org/10.1371/journal.pone.0259707
_version_ 1784600724856897536
author Turjeman, Adi
Koppel, Fidi
Franceschini, Erica
Yahav, Dafna
Dolci, Giovanni
Babich, Tanya
Bitterman, Roni
Neuberger, Ami
Ghanem-Zoubi, Nesrin
Santoro, Antonella
Eliakim-Raz, Noa
Pertzov, Barak
Stern, Anat
Dickstein, Yaakov
Maroun, Elias
Zayyad, Hiba
Meschiari, Marianna
Bishara, Jihad
Goldberg, Elad
Venturelli, Claudia
Mussini, Cristina
Paul, Mical
Leibovici, Leonard
author_facet Turjeman, Adi
Koppel, Fidi
Franceschini, Erica
Yahav, Dafna
Dolci, Giovanni
Babich, Tanya
Bitterman, Roni
Neuberger, Ami
Ghanem-Zoubi, Nesrin
Santoro, Antonella
Eliakim-Raz, Noa
Pertzov, Barak
Stern, Anat
Dickstein, Yaakov
Maroun, Elias
Zayyad, Hiba
Meschiari, Marianna
Bishara, Jihad
Goldberg, Elad
Venturelli, Claudia
Mussini, Cristina
Paul, Mical
Leibovici, Leonard
author_sort Turjeman, Adi
collection PubMed
description OBJECTIVE: To identify risk factors for functional decline after hospitalization for Gram-negative bacteremia. PATIENTS AND METHODS: A prospective cohort study based on a randomized controlled trial conducted between January 1, 2013 and August 31, 2017 in Israel and Italy. Hospitalized patients with Gram-negative bacteremia who survived until day 90 and were not bedridden at baseline were included. The primary end point was functional decline at 90 days. RESULTS: Five hundred and nine patients were included. The median age of the cohort was 71 years (interquartile range [IQR], 60–80 years), 46.4% (236/509) were male and 352 of 509 (69%) patients were independent at baseline. Functional decline at 90 days occurred in 24.4% of patients (124/509). In multivariable analysis; older age (odds ratio [OR], 1.03; for an one-year increment, 95% confidence interval [CI] 1.01–1.05), functional dependence in instrumental activities of daily living at baseline (OR, 4.64; 95% CI 2.5–8.6), low Norton score (OR, 0.87; 95% CI 0.79–0.96) and underlying comorbidities: cancer (OR, 2.01; 95% CI 1.14–3.55) and chronic pulmonary disease (OR, 2.23 95% CI 1.12–4.42) and longer length of hospital stay (OR 1.09; for one-day increment, 95% CI 1.04–1.15) were associated with functional decline. Appropriate empirical antibiotic treatment was associated with lower rates of functional decline within 90 days (OR, 0.4; 95% CI 0.21–0.78). CONCLUSIONS: Patients surviving bloodstream infections have poor long term trajectories after clinical recovery and hospital discharge. This has vast implications for patients, their family members and health policy makers.
format Online
Article
Text
id pubmed-8598031
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-85980312021-11-18 Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study Turjeman, Adi Koppel, Fidi Franceschini, Erica Yahav, Dafna Dolci, Giovanni Babich, Tanya Bitterman, Roni Neuberger, Ami Ghanem-Zoubi, Nesrin Santoro, Antonella Eliakim-Raz, Noa Pertzov, Barak Stern, Anat Dickstein, Yaakov Maroun, Elias Zayyad, Hiba Meschiari, Marianna Bishara, Jihad Goldberg, Elad Venturelli, Claudia Mussini, Cristina Paul, Mical Leibovici, Leonard PLoS One Research Article OBJECTIVE: To identify risk factors for functional decline after hospitalization for Gram-negative bacteremia. PATIENTS AND METHODS: A prospective cohort study based on a randomized controlled trial conducted between January 1, 2013 and August 31, 2017 in Israel and Italy. Hospitalized patients with Gram-negative bacteremia who survived until day 90 and were not bedridden at baseline were included. The primary end point was functional decline at 90 days. RESULTS: Five hundred and nine patients were included. The median age of the cohort was 71 years (interquartile range [IQR], 60–80 years), 46.4% (236/509) were male and 352 of 509 (69%) patients were independent at baseline. Functional decline at 90 days occurred in 24.4% of patients (124/509). In multivariable analysis; older age (odds ratio [OR], 1.03; for an one-year increment, 95% confidence interval [CI] 1.01–1.05), functional dependence in instrumental activities of daily living at baseline (OR, 4.64; 95% CI 2.5–8.6), low Norton score (OR, 0.87; 95% CI 0.79–0.96) and underlying comorbidities: cancer (OR, 2.01; 95% CI 1.14–3.55) and chronic pulmonary disease (OR, 2.23 95% CI 1.12–4.42) and longer length of hospital stay (OR 1.09; for one-day increment, 95% CI 1.04–1.15) were associated with functional decline. Appropriate empirical antibiotic treatment was associated with lower rates of functional decline within 90 days (OR, 0.4; 95% CI 0.21–0.78). CONCLUSIONS: Patients surviving bloodstream infections have poor long term trajectories after clinical recovery and hospital discharge. This has vast implications for patients, their family members and health policy makers. Public Library of Science 2021-11-17 /pmc/articles/PMC8598031/ /pubmed/34788325 http://dx.doi.org/10.1371/journal.pone.0259707 Text en © 2021 Turjeman et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Turjeman, Adi
Koppel, Fidi
Franceschini, Erica
Yahav, Dafna
Dolci, Giovanni
Babich, Tanya
Bitterman, Roni
Neuberger, Ami
Ghanem-Zoubi, Nesrin
Santoro, Antonella
Eliakim-Raz, Noa
Pertzov, Barak
Stern, Anat
Dickstein, Yaakov
Maroun, Elias
Zayyad, Hiba
Meschiari, Marianna
Bishara, Jihad
Goldberg, Elad
Venturelli, Claudia
Mussini, Cristina
Paul, Mical
Leibovici, Leonard
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title_full Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title_fullStr Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title_full_unstemmed Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title_short Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study
title_sort risk factors for functional decline among survivors of gram-negative bloodstream infection: a prospective cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598031/
https://www.ncbi.nlm.nih.gov/pubmed/34788325
http://dx.doi.org/10.1371/journal.pone.0259707
work_keys_str_mv AT turjemanadi riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT koppelfidi riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT franceschinierica riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT yahavdafna riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT dolcigiovanni riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT babichtanya riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT bittermanroni riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT neubergerami riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT ghanemzoubinesrin riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT santoroantonella riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT eliakimraznoa riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT pertzovbarak riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT sternanat riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT dicksteinyaakov riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT marounelias riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT zayyadhiba riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT meschiarimarianna riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT bisharajihad riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT goldbergelad riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT venturelliclaudia riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT mussinicristina riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT paulmical riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy
AT leibovicileonard riskfactorsforfunctionaldeclineamongsurvivorsofgramnegativebloodstreaminfectionaprospectivecohortstudy